From: After 'completion': the changing face of human chromosomes 21 and 22
Gene symbol | Total publications | Publications since [1] | OMIM number | Disorder |
---|---|---|---|---|
DGCR | 91 | 18 (20%) | 188400 | DiGeorge syndrome; velocardiofacial syndrome |
DIA1 | 80 | 5 (6%) | 250800 | Methemoglobinemia, type I; methemoglobinemia, type II |
CYP2D | 75 | 7 (9%) | 124030 | Debrisoquine sensitivity; {possible susceptibility to Parkinsonism} |
BCR | 71 | 18 (25%) | 151410 | Chronic myeloid leukemia; acute lymphocytic leukemia |
OGS2 | 60 | 0 (0%) | 145410 | Opitz G syndrome, type II |
NF2 | 56 | 22 (39%) | 607379 | Neurofibromatosis, type 2; NF2-related somatic meningioma; schwannomatosis |
TCN2 | 53 | 3 (6%) | 275350 | Transcobalamin II deficiency |
CTLO | 51 | 9 (18%) | 218040 | Possibly Costello syndrome |
ARSA | 51 | 5 (10%) | 607574 | Metachromatic leukodystrophy |
COMT | 48 | 13 (27%) | 116790 | {Possible susceptibility to schizophrenia} |
CECR | 48 | 1 (2%) | 115470 | Cat eye syndrome |
PDGFB | 39 | 2 (5%) | 190040 | SIS-related meningioma; dermatofibrosarcoma protuberans; giant-cell fibroblastoma |
EWSR1 | 38 | 1 (3%) | 133450 | Ewing sarcoma; neuroepithelioma; extraskeletal myxoid chondrosarcoma |
CHEK2 | 24 | 20 (83%) | 604373 | Li-Fraumeni syndrome; somatic osteosarcoma; {possible susceptibility to breast cancer}; familial prostate cancer; {possible susceptibility to breast and colorectal cancer} |
SOX10 | 24 | 10 (42%) | 602229 | Waardenburg-Shah syndrome; Yemenite deaf-blind hypopigmentation syndrome; neurologic variant Waardenburg-Shah syndrome |
NAGA | 23 | 1 (4%) | 104170 | Schindler disease; Kanzaki disease; mild NAGA deficiency |
ACF | 21 | 1 (5%) | 125520 | Cayler cardiofacial syndrome |
MYH9 | 20 | 12 (60%) | 160775 | May-Hegglin anomaly; Fechtner syndrome; Sebastian syndrome; autosomal dominant deafness 17; Epstein syndrome |
EP300 | 16 | 8 (50%) | 602700 | Colorectal cancer |
TIMP3 | 16 | 6 (38%) | 188826 | Sorsby fundus dystrophy |
SMARCB1 | 16 | 3 (19%) | 601607 | Rhabdoid tumors; rhabdoid familial predisposition syndrome |
CTHM | 16 | 2 (13%) | 217095 | ? Conotruncal cardiac anomalies |
SCZD4 | 15 | 2 (13%) | 600850 | {Possible susceptibility to schizophrenia} |
ADSL | 15 | 2 (13%) | 608222 | Adenylosuccinase deficiency |
NEFH | 15 | 0 (0%) | 162230 | {Possible susceptibility to amyotrophic lateral sclerosis} |
SLC5A1 | 15 | 0 (0%) | 182380 | Glucose/galactose malabsorption |
CRYBB2 | 12 | 2 (17%) | 123620 | Cataract, cerulean, type 2; cataract, sutural, with punctate and cerulean opacities |
GGT1 | 12 | 0 (0%) | 231950 | Glutathioninuria |
A4GALT | 11 | 5 (45%) | 607922 | [Blood group, P system] |
HMOX1 | 11 | 5 (45%) | 141250 | Heme oxygenase-1 deficiency |
CSF2RB | 11 | 1 (9%) | 138981 | Pulmonary alveolar proteinosis |
ACR | 11 | 0 (0%) | 102480 | {Possible male infertility due to acrosin deficiency} |
MLC1 | 10 | 8 (80%) | 605908 | Megalencephalic leukoencephalopathy with subcortical cysts |
SCA10 | 10 | 5 (50%) | 603516 | Spinocerebellar ataxia-10 |
FBLN1 | 10 | 2 (20%) | 135820 | Synpolydactyly, 3/3'4, associated with metacarpal and metatarsalsynostoses |
GP1BB | 9 | 1 (11%) | 138720 | Bernard-Soulier syndrome, type B; isolated giant platelet disorder |
HCF2 | 9 | 0 (0%) | 142360 | Thrombophilia due to heparin cofactor II deficiency |
RAC2 | 8 | 6 (75%) | 602049 | Neutrophil immunodeficiency syndrome |
PRODH | 8 | 5 (63%) | 606810 | Hyperprolinemia, type I; {possible susceptibility to schizophrenia} |
GGT2 | 8 | 0 (0%) | 137181 | [Familial high serum gamma-glutamyltransferase] |
HIRA | 8 | 0 (0%) | 600237 | {Possible role in CATCH22} |
IGLL1 | 7 | 1 (14%) | 146770 | Autosomal agammaglobulinemia recessive |
APOL1 | 6 | 5 (83%) | 603743 | {Possible susceptibility to schizophrenia} |
XBP1 | 6 | 4 (67%) | 194355 | {Possible susceptibility to schizophrenia} |
SCO2 | 6 | 4 (67%) | 604272 | Fatal infantile cardioencephalomyopathy due to cytochrome coxidase deficiency |
ECGF1 | 6 | 2 (33%) | 131222 | Myoneurogastrointestinal encephalomyopathy syndrome |
PVALB | 6 | 1 (17%) | 168890 | {Possible role in DiGeorge syndrome} |
APOL2 | 4 | 4 (100%) | 607252 | {Possible susceptibility to schizophrenia} |
APOL4 | 4 | 4 (100%) | 607254 | {Possible susceptibility to schizophrenia} |
MKL1 | 4 | 4 (100%) | 606078 | Acute megakaryoblastic leukemia |
LARGE | 4 | 3 (75%) | 603590 | {Possibly meningioma} |
HPS4 | 4 | 3 (75%) | 606682 | Hermansky-Pudlak syndrome |
SYN3 | 4 | 1 (25%) | 602705 | {Possible relation to schizophrenia} |
KAZA | 3 | 3 (100%) | 608207 | {Possible susceptibility to Kala-azar} |
PSAP2 | 3 | 2 (67%) | 606230 | Chromosome 22q13.3 deletion syndrome |
UFD1L | 3 | 1 (33%) | 601754 | {Possible role in CATCH22} |
MN1 | 3 | 0 (0%) | 156100 | Meningioma |
ALG12 | 2 | 2 (100%) | 607144 | Congenital disorder of glycosylation, type Ig |
FPEVF | 2 | 0 (0%) | 604364 | Partial epilepsy with variable foci |
ARVCF | 2 | 0 (0%) | 602269 | {Possible role in VCFS} |
DFNB40 | 1 | 1 (100%) | 608264 | Autosomal recessive deafness 40 |
ITS | 1 | 1 (100%) | 606960 | Insulinoma |